Investor Ingalls & Snyder Llc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Ingalls & Snyder Llc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-02-21 13G/A OMER / Omeros Corporation 4,431,188 4,161,315
2025-02-21 13G/A DRRX / DURECT Corporation 2,558,012 2,681,770
2025-02-21 13G/A CORT / Corcept Therapeutics Incorporated 8,262,476 8,173,721
2025-02-21 13G/A STRS / Stratus Properties Inc. 981,057 1,092,084
2025-02-14 13G/A AERG / Applied Energetics, Inc. 18,580,236 18,158,048
2024-03-27 13G DRRX / DURECT Corporation 7,707,372 2,558,012
2024-03-27 13G/A STRS / Stratus Properties Inc. 1,108,040 981,057
2024-03-27 13G/A OMER / Omeros Corporation 4,131,793 4,431,188
2024-03-27 13G/A AERG / Applied Energetics, Inc. 25,057,965 18,580,236
2024-03-27 13G/A CORT / Corcept Therapeutics Incorporated 7,090,370 8,262,476
2024-02-27 13G IPA / ImmunoPrecise Antibodies Ltd. 1,053,186 1,317,819
2023-07-07 13D IPA / ImmunoPrecise Antibodies Ltd. 1,053,186
2023-02-17 13G/A STRS / Stratus Properties Inc. 1,159,066 1,108,040
2023-02-17 13G/A OMER / Omeros Corporation 4,464,492 4,131,793
2023-02-17 13G/A CORT / Corcept Therapeutics Incorporated 6,655,977 7,090,370
2023-02-17 13G/A AERG / Applied Energetics, Inc. 16,864,104 25,057,965
2022-02-04 13G AERG / Applied Energetics, Inc. 16,864,104
2022-02-04 13G/A STRS / Stratus Properties Inc. 1,239,896 1,159,066
2022-02-04 13G/A OMER / Omeros Corporation 4,748,189 4,464,492
2022-02-04 13G/A CORT / Corcept Therapeutics Incorporated 7,583,772 6,655,977
2021-11-22 13D/A INUV / Inuvo, Inc. 5,250,109 5,621,023
2021-02-09 13G/A STRS / Stratus Properties Inc. 1,281,013 1,239,896
2021-02-09 13G/A OMER / Omeros Corporation 5,030,671 4,748,189
2021-02-09 13G/A CORT / Corcept Therapeutics Incorporated 8,285,930 7,583,772
2021-02-09 13G/A CNCE / Concert Pharmaceuticals Inc 1,464,712 1,396,003
2021-02-01 13D/A INUV / Inuvo, Inc. 5,402,486 5,250,109
2020-02-28 13D/A INUV / Inuvo, Inc. 4,201,992 5,402,486
2020-02-07 13G/A CORT / Corcept Therapeutics Incorporated 8,643,023 8,285,930
2020-02-07 13G/A OMER / Omeros Corporation 5,582,273 5,030,671
2020-02-07 13G/A USAS / Americas Gold and Silver Corporation 4,089,626 3,141,726
2020-02-07 13G/A STRS / Stratus Properties Inc. 1,461,000 1,281,013
2020-02-07 13G/A MOSY / Mosys Inc 4,302,436 314,423
2020-01-23 13G/A DRRX / DURECT Corporation 8,372,421 7,707,372
2020-01-23 13G/A CNCE / Concert Pharmaceuticals Inc 1,199,775 1,464,712
2019-07-19 13D INUV / Inuvo, Inc. 2,349,471 4,201,992
2019-01-30 13G/A OMER / Omeros Corporation 5,714,180 5,582,273
2019-01-30 13G/A STRS / Stratus Properties Inc. 1,517,020 1,461,000
2019-01-30 13G/A MOSY / Mosys Inc 3,644,050 4,302,436
2019-01-30 13G/A CNCE / Concert Pharmaceuticals Inc 1,332,662 1,199,775
2019-01-30 13G/A CORT / Corcept Therapeutics Incorporated 7,217,724 8,643,023
2019-01-30 13G/A DRRX / DURECT Corporation 8,486,721 8,372,421
2019-01-30 13G/A USAPF / Americas Silver Corporation 4,185,409 4,089,626
2018-10-30 13G/A MOSY / Mosys Inc 888,048 3,644,050
2018-06-26 13D INUV / Inuvo, Inc. 2,349,471
2018-05-11 13G/A MOSY / Mosys Inc 836,488 888,048
2018-02-09 13G CNCE / Concert Pharmaceuticals Inc 1,332,662
2018-02-09 13G DRRX / DURECT Corporation 8,486,721
2018-02-09 13G/A OMER / Omeros Corporation 5,097,510 5,714,180
2018-02-09 13G/A USAPF / Americas Silver Corporation 2,764,808 4,185,409
2018-02-09 13G/A MOSY / Mosys Inc 15,574,018 836,488
2018-02-09 13G/A STRS / Stratus Properties Inc. 1,370,302 1,517,020
2018-02-08 13G/A CORT / Corcept Therapeutics Incorporated 8,083,697 7,217,724
2017-02-15 13G USAPF / Americas Silver Corporation 2,764,808
2017-02-14 13G/A GTY / Getty Realty Corp. 1,821,331 1,016,835
2017-02-14 13G/A STRS / Stratus Properties Inc. 1,381,396 1,370,302
2017-02-14 13G/A MOSY / Mosys Inc 15,123,336 15,574,018
2017-02-14 13G/A OMER / Omeros Corporation 3,760,620 5,097,510
2017-02-14 13G/A CORT / Corcept Therapeutics Incorporated 8,933,637 8,083,697
2016-03-22 13G/A MOSY / Mosys Inc 9,668,781 15,123,336
2016-02-19 13G GTY / Getty Realty Corp. 1,821,331 1,821,331
2016-02-09 13G GTY / Getty Realty Corp. 1,821,331
2016-02-09 13G/A CORT / Corcept Therapeutics Incorporated 8,933,637
2016-02-05 13G/A MOSY / Mosys Inc 8,794,050 9,668,781
2016-02-05 13G/A STRS / Stratus Properties Inc. 1,381,396
2016-02-05 13G/A OMER / Omeros Corporation 3,760,620
2015-03-05 13G/A MOSY / Mosys Inc 8,794,050
2015-02-06 13G/A ASRT / Assertio Holdings, Inc. 750
2015-02-06 13G/A STRS / Stratus Properties Inc. 1,340,819
2015-02-06 13G/A AGEN / Agenus Inc. 0
2015-02-06 13G/A CORT / Corcept Therapeutics Incorporated 7,772,745
2015-02-06 13G/A OMER / Omeros Corporation 2,347,987
2015-02-06 13G/A MOSY / Mosys Inc 7,822,050
2015-02-06 13G/A THTX / Theratechnologies Inc. 1,949,000
2014-09-12 13G/A AVNR / Avanir Pharmaceuticals Inc 6,575,201
2014-04-01 13G/A OMER / Omeros Corporation 1,717,860
2014-02-07 13G/A ASRT / Assertio Holdings, Inc. 4,381,750
2014-02-07 13G/A CORT / Corcept Therapeutics Incorporated 6,043,804
2014-02-07 13G/A AGEN / Agenus Inc. 2,000,000
2014-02-07 13G/A THTX / Theratechnologies Inc. 4,652,205
2014-02-07 13G/A AVNR / Avanir Pharmaceuticals Inc 11,118,891
2014-02-07 13G/A STRS / Stratus Properties Inc. 1,298,549
2014-02-07 13G/A MOSY / Mosys Inc 6,033,789
2013-07-11 13G/A OMER / Omeros Corporation 1,293,985
2013-04-18 13G AGEN / Agenus Inc. 2,116,034
2013-04-11 13G OMER / Omeros Corporation 1,322,885
2013-01-28 13G/A ASRT / Assertio Holdings, Inc. 4,516,750
2013-01-28 13G/A CORT / Corcept Therapeutics Incorporated 5,847,151
2013-01-28 13G/A THTX / Theratechnologies Inc. 6,515,325
2013-01-28 13G/A 1,418,663
2013-01-28 13G/A AVNR / Avanir Pharmaceuticals Inc 12,844,885
2013-01-28 13G/A STRS / Stratus Properties Inc. 1,285,069
2013-01-28 13G/A MOSY / Mosys Inc 5,064,242
2013-01-28 13G/A ALSE / Alseres Pharmaceuticals, Inc. 100,000
2012-08-31 13G/A DCO / Ducommun Incorporated 523,608
2012-08-17 13G/A SOMX / Somaxon Pharmaceuticals, Inc. 2,357,500
2012-08-17 13G DCO / Ducommun Incorporated 542,858
2012-08-06 13G/A SOMX / Somaxon Pharmaceuticals, Inc. 4,595,000
2012-03-20 13G/A AGEN / Agenus Inc. 1,001,422
2012-02-07 13G/A ASRT / Assertio Holdings, Inc. 3,469,000
2012-02-07 13G/A MSW / Ming Shing Group Holdings Limited 1,764,610
2012-02-07 13G/A CORT / Corcept Therapeutics Incorporated 4,998,552
2012-02-07 13G/A AGEN / Agenus Inc. 1,282,517
2012-02-07 13G/A SOMX / Somaxon Pharmaceuticals, Inc. 5,957,000
2012-02-07 13G/A THTX / Theratechnologies Inc. 6,127,045
2012-02-07 13G/A 1,800,926
2012-02-07 13G/A AVNR / Avanir Pharmaceuticals Inc 13,715,140
2012-02-07 13G/A STRS / Stratus Properties Inc. 1,344,838
2012-02-07 13G/A MOSY / Mosys Inc 4,144,992
2012-02-07 13G/A ALSE / Alseres Pharmaceuticals, Inc. 3,403,969